MIHGH Presentations 2007- present

E-mail Print PDF
  • Albert AE, Wheeler R, Hoelz DJ. 2010. The role of Arm1 in DNA lesion bypass.” Maine Biological and Medical Sciences Symposium, April, Mount Desert Island, ME
  • Bult C. 2009. The Maine Cancer GIS project. Meeting of National and Maine chapters of the Ladies Auxiliary of the Veterans of Foreign Wars (LAVFW), February.
  • Carlson P & Van Beneden RJ. 2011. A Proteomic Analysis of arsenic-expose zebrafish suggests altered lipid metabolism. Oral presentation, Society of Toxicology, annual meeting March 6-10, 2011.
  • Carlson P, Dalrymple AE, Hock, JM, Van Beneden, RJ. 2012. Transplacental arsenic exposure induces gender-specific gene expression changes in fatty acid metabolism in C57BL/6 mouse liver. Abstract submitted to the annual meeting of the Society of Toxicology, San Francisco, USA, March 11-15, 2012.
  • Chai G, Liu N, Ma J, Li H, Chang L-S, Wallace M, Guha A, Phipps RJ, Hock JM, Yu X. 2009. MicroRNA-10b Represses Neurofibromin and Regulates NF1 Tumorigenesis. NF International meeting, Portland, OR.
  • Cox A, Helbig P0, Chavaree M, Goodspeed D, Farah C, Farah, Hock JM. 2009. BioGeoBank of Maine: Methods Used in Processing Blood Samples. Atlantic Omics Symposium, Moncton, NB, Canada. June 18-19.
  • Dalrymple AE, Newman CL, Lukas J, Hock JM, Van Beneden RJ, 2011. Transplacental exposures and transgenerational effects of low dose exposure to arsenic in female mice. 38th Maine Biological and Medical Sciences Symposium. Maine, ME.
  • Dalrymple, AE, Newman, CL, Hock, JM, and Van Beneden, RJ. 2012. Transplacental low-dose exposure of female mice to arsenic induces alteration in gene expression and DNA methylation patterns of cell cycle regulatory genes in offspring. Annual meeting of the Society of Toxicology, San Francisco, USA, March 11-15, 2012.
  • Demers CJ, Smith RL, Hock JM, Collins SD. 2011. Combinatorial cell microenvironment generator. 38th Maine Biological and Medical Sciences Symposium. Maine, ME.
  • Donghia NM, Tompkins K, Maas SA, Mills KD. 2009. The DNA Repair Factor, ARTEMIS, Suppresses Sarcomagenesis and is Required for Normal Mesenchymal Stem Cell Function Northeast Regional IDeA Meeting (NCRR), August.
  • Doore S. 2009. Conceptual model for representing individual exposure histories. URISA GIS in Public Health Conference, Providence, RI, June 5-8.
  • Farah C, Laub P, Hock JM, Chavaree M, Helbig P, Goodspeed D. 2008. Maine tissue repository: refining the epidemiological view for cancer research. Atlantic Omics Symposium and Expo, Moncton, NB, Canada.
  • Farah C, Laub P, Chavaree M, Hock JM. 2009. Systems to Address Cancer in Maine. MIHGH-UNE-VA-EMHS sponsored New Horizons in Human Health Symposium: Bringing Leading Edge Medicine to Rural Communities, March 13-14, Hallowell, Maine
  • Farah, C. 2009. Incorporating a GIS to Facilitate Translational Research and Promote Public Health Policies Maine Department of Environmental Protection, Bureau of Land and Water Quality. Bangor, ME.
  • Farah C, Cox A, Goodspeed D, Helbig P, Laub P, Hock JM. 2009. Identifying Trends in Cancer in Maine. Atlantic Omics Symposium, Moncton, NB, Canada. June 18-19.
  • Farah, C. 2010. Analyzing environmental exposures in Maine using GIS technologies. Eastern Maine Healthcare Systems, IS Directors Group, Clinical Res. Management System for Biobanking. Brewer, ME.
  • Farah C, HD Hosgood, JM Hock. 2011. User Gateway: Linking spatial and temporal information on environments with biobanking to assess the associations between human health and mixtures of environmental exposures. 4th Annual NCI Biospecimen Research Network Symposium. Washington, DC.
  • Farah C, Hock JM. 2012. User Gateway: A system to accelerate molecular epidemiology. World Bio-IT meeting. Boston, MA. April, 2012.
  • Helbig P, Laub P, Chavaree M, Goodspeed D, Farah C, Hock JM. 2009. BioGeoBank of Maine: The use of mdlogix’s Clinical Research Management System (CRMS). MIHGH-UNE-VA-EMHS sponsored New Horizons in Human Health Symposium: Bringing Leading Edge Medicine to Rural Communities, March 13-14, Hallowell, Maine
  • Hock JM, Page J, Ott G, DeSelle C. 2009. Application of GIS in the Study of Genetics, Genomics, Cancer & the Environment. URISA GIS in Public Health Conference, Providence, RI, June 5-8.
  • Hock JM, Farah. 2010. Environmental oncology and GIS: radon and arsenic risks in Maine. National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, Maryland.
  • Hock JM, Farah C, Li X. 2010. Environmental health risks in Maine’s rural communities. Eastern Maine Medical Center Grand Rounds. October. Bangor, ME (CME)
  • Hock, JM. 2010. “A world in a grain of sand and a heaven in a wildflower..” Research Day Speaker, Husson College School of Pharmacy, Bangor.
  • Hock, JM. 2010. Osteosarcoma. Husson University School of Pharmacy student lecture, Bangor, ME.
  • Hock JM. 2010. Stem cell biology for the clinic. Int. Congress on External Fixation and Bone Reconstruction. Oct 20-22. Barcelona, Spain
  • Hock JM, Farah C. 2011. The BioGeoBank User Gateway: Enhancing health information. Bio-IT World. Boston, MA.
  • Hock JM, Farah C, HD Hosgood, M Schwenn, C Black. 2012. Spatial analyses reveal increased incidence of large cell lung carcinoma in specific regions of Maine that differ in men and women. Amer Assoc Cancer Res Lung Cancer Symposium. San Diego. Jan 2012. Poster.
  • Hock JM, Farah C, Morrison DG. 2012. Gender, Environment and Diagnosis influence spatial distribution of respiratory diseases and lung cancers in Maine. Eastern Maine Medical Center Grand Rounds, Bangor, ME.
  • Hoelz DJ, Albert A, Dobrolecki LE, Arnold R, Schnaper L, Novotny M, Hickey R, Malkas L. 2009. Arm1: a glutamate methyltransferase capable of methyl esterifying PCNA. AACR conference Frontiers in Basic Cancer Research, Boston, MA.
  • Hoelz DJ. 2009. PCNA methyl esterification and the DNA damage response. U Southern Maine Seminar Series.
  • Hoelz DJ. 2009. PCNA Methyl Esterification is Required for DNA Repair. U Maine Seminar Series, Dept Chemistry.
  • M Kawai, VE DeMambro, A Breggia, WG Beamer, DR Clemmons, CJ Rosen. 2009IGFBP-2 regulates bone turnover likely through a mechanism independent of IGF-1 binding.. Endocrinol Ann Mtg, Washington DC
  • Laub PB, Chavaree M, Farah C, Hayes MJ, Helbig P, Hock JM. 2008. Mapping the influence of demographic and health risk factors on cancer incidence in the United States. Atlantic Omics Symposium and Expo, Moncton, NB, Canada.
  • Laub P, Helbig P, Chavaree M, Goodspeed D, Farah C, Hock JM.. 2009. Geospatial and Temporal Characterization of Cancer in Maine. MIHGH-UNE-VAEMHS sponsored New Horizons in Human Health Symposium: Bringing Leading Edge Medicine to Rural Communities, March 13-14, Hallowell, Maine
  • Li X, Liu Y, Fang G. 2009. A chemo-gene therapeutic modality maximizes antitumor efficacy by enhancing cell apoptosis, virus distribution and transgene expression in prostate cancer model. 36th Maine Biological and Medical Sciences Symposium, MDIBL
  • X Li. 2009. Sensitization of cancer cells to ligand-induced apoptosis. Dpt Biochemistry, Microbiology and Molecular Biology. U Maine.
  • Li X, Liu Y, Sullivan C, Cox A. 2010. Up-regulation of FOXM1 Promotes Lung Carcinogenesis Induced by the Exposure of Low Doses of Arsenite. 37th Maine Biological and Medical Sciences Symposium, ME.
  • Li X. 2010. Cancer Signal Transduction and Molecular Targeted Therapy. The first affiliated hospital, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China
  • Li X. 2010. Cell Death Pathways and Cancer Targeted Therapy. School of Basic Pharmaceutics, Yat-sen Sun University, Guangzhou, P.R. China
  • Li X. 2010. Arsenic, a Double-Edged Sword in Cancer Therapy and Carcinogenesis. National Key Laboratory of Cancer, Zhongnan University, Changsha, P.R. China
  • Li X. 2010. Molecular Signaling Pathways Involved in Low-Dose Arsenic-Induced Cell Proliferation and Malignant Transformation. 2nd WestLake International conference of translational medicine, Hangzhou, P.R. China
  • Li X. 2010. Molecular signaling involved in low doses of arsenic-promoted cell proliferation. Invited talk. 37th Maine Biological and Medical Sciences Symposium, Salisbury Cove, ME
  • Little KM, Smalley DM, Harthun NL, Ley K. 2010. The plasma microparticle proteome updated. Experimental Biology meeting. April 24 – 28, 2010
  • Liu N, Chai G, Ma, J Phipps RJ, Hock JM, Yu X. 2009. Abnormal Osteoblast Development from Nf1 Null Embryonic Stem Cells. Amer Soc Bone & Min Res meeting in Denver, CO.
  • Liu N, Chai G, Ma J, Phipps RJ, Hock JM, Yu X. 2009. Using Mouse Embryonic Stem Cells to Re-create Osteoblast Development in Neurofibromatosis Type I NF International meeting, Portland, OR.
  • Liu N, Chai G, Coombs HF, Shultz KL, Wei L, Beamer WG, Phipps RJ, Hock JM, Yu X. 2009. Hyperactivation of mTOR Critically Regulates Abnormal Osteoclastogenesis in NF1. NF International meeting, Portland, OR.
  • Liu N, Chai G, Ma J, Phipps RJ, Hock JM, Yu X. 2009. Abnormal Osteoblast Development from Nf1 Null Embryonic Stem Cells. ASBMR Internat Mtg, Denver, CO.
  • Liu Y, Sullivan C, Fang G, Cox A, Li X. 2010. Molecular signaling involved in low doses of arsenic-promoted cell proliferation. 2th Westlake International Medicine Conference, Hangzhou, P.R. China. Acta Biochim Biophys Sin 42 (Supplement 1): i19
  • Liu Y, Sullivan C, Li. X 2011. Up-regulation of FOXM1 Promotes Lung Carcinogenesis Induced by the Exposure of Low Doses of Arsenite. 38th Maine Biological and Medical Sciences Symposium, Salisbury Cove, ME.
  • Liu Y, Sullivan C, Li. X 2011. Up-regulation of FOXM1 Promotes Lung Carcinogenesis Induced by the Exposure of Low Doses of Arsenite. 102nd American Association of Cancer Research (AACR) annual meeting in Orlando, FL.
  • Liu Y, Li X. 2011 FOXM1 and AR Interact to Regulate CDC6 Gene Transcription and DNA Replication in Prostate Cancer Cells. American Society of Cell Biology (ASCB) Annual Meeting in Denver, CO, December 3-7, 2011 (Poster Presentation).
  • Liu Y, Li X. 2011 FOXM1 and AR Interact to Regulate CDC6 Gene Transcription and DNA Replication in Prostate Cancer Cells. Gordon Research Conference Cell Growth and Proliferation, Portland, ME. June, 2011 (Poster Presentation)
  • Lynch RP, Sitarski A, Smalley DM. 2009. A Proteomic Analysis of Bronchial Epithelial Cells Following Exposure to Low Levels of Arsenic Trioxide. Atlantic OMICS Symposium, June 18-19, 2009, Moncton, New Brunswick, CA
  • Lynch RP, Smalley DM. 2010. A Proteomic Analysis of Lung Epithelial Cells Following Exposure to the Endocrine Disruptive Chemicals 2,3,7,8-tetrachlorodibenzo-p-dioxin and Arsenic Trioxide. HUPO (Human Proteome) meeting. March 7 – 10, 2010.
  • Maas SA, Tompkins K, Mills KD 2009 DNA break repair restrains bone marrow stromal cell proliferation, and suppresses mesenchyme-derived tumors. Ann Mtg Amer Assoc Cancer Res (AACR), Denver, CO.
  • Mathews D, Hamilton W, White A, Windhorst C, Hock JM. 2011. Identifyign kitchen skills, child-feeding practices and quality of life in rura; makers of meals for children 2 to 12 years. J Nutr.Educ. Behav. 43:S6
  • Mathews D, Windhorst C, Hock JM, White AA. 2013. The Makers of Meals Program. Society of Nutrition Education and Behavior Meeting.
  • Morrison DG, Farah C, Hock JM. 2012. Informed consent in biobank research: recruiting patients with health disparities in rural Maine. NCI OBBR 5th Ann Biospecimen Research network Symposium. Bethesda, MD. Feb 2012. Poster and Lunch Discussion Leader.
  • Morrison DG, Farah C, Hock JM. 2012. Informed consent in biobank research: Recruiting patients with health disparities in rural Maine. NIH NCI BRN meeting, Bethesda, MD. April 2012.
  • Sigmon ST, Hayes M, Matano B, Lodis C, Alderfer M, Hock JM. 2009. Risk and Resiliency Factors in the Development of Posttraumatic Stress in the Well Siblings of Children with Cancer. Association for Behavioral and Cognitive Therapies Ann. Mtg, New York, Feb.
  • Sitarski A, Lynch RP, and Smalley DM, “Optimization of Phosphopeptide Analysis by MALDI-TOF/TOF” Mount Desert Island Stem Cell Symposium: Reprogramming and Epigenetics, Salisbury Cove, ME (Poster)
  • Smalley DM. 2008. Discovery of Biomarkers for Abdominal Aortic Aneurysm”, American Heart Association National Meeting, New Orleans, LA (oral)
  • Smalley DM. 2009. Selection of Microparticles (MPs) for Biomarker Discovery by Mass Spectrometry. 36th Maine Biological and Medical Symposium, April 17-18, 2009, Salisbury Cove, ME.
  • Sullivan C., Shen J. Liu YH, Li X. 2011. FOXM1 and CDC25A Interact in a Positive Regulatory Loop to Regulate G1/S Cell Cycle Transition. Gordon Research Conference Cell Growth and Proliferation, Portland, ME. June, 2011 (Oral Presentation)
  • Sullivan C., Shen J. Liu YH, Li X, 2011. FOXM1 and CDC25A Interact in a Positive Regulatory Loop to Regulate G1/S Cell Cycle Transition. 38th Maine Biological and Medical Sciences Symposium, Salisbury Cove, ME.
  • Sullivan C, Shen J, Liu Y, Curtis A, Newman C Li X. 2011. FOXM1 and CDC25A cooperate to regulate the G1/S cell cycle transition. Cell Growth & Proliferation Gordon Research Seminar. Biddeford, ME
  • Sullivan C, Shen J, Liu Y, Curtis A, Newman C, Li X. 2011. FOXM1 and CDC25A interact at the transcriptional and post-translational levels to regulate the G1/S cell cycle transition. 39th Maine Biological and Medical Sciences Symposium, Salisbury Cove, ME.
  • Tompkins K, Maas SA, Mills KD. 2008 DNA break repair restrains bone marrow stromal cell proliferation, and suppresses mesenchyme-derived tumors. 2nd Biennial National IDeA Symposium of Biomedical Research Excellence, Washington D.C.
  • Van Beneden, RJ. 2011. Translation Toxicology: Fishing for Answers. School of Marine Sciences, U Maine.
  • Yu X, Ma J, Hock JM. 2010. Hyperactivation of mTOR Critically Regulates Abnormal Osteoclastogensis in Neurofibromatosis Type 1. 5th International Conference on Osteoporosis and Bone Research. October 28-31, Shenzhen, China.
  • Yu X, Ma J, Gong M, Guillemette R, Hock JM. 2010. Abnormal Osteoblast Development from Nf1 Null Embryonic Stem Cells. 5th International Conference on Osteoporosis and Bone Research. October 28-31, Shenzhen, China.